Semintra Telmisartan 4 Mg/Ml
124 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
124
Total Reports
15
Deaths Reported
1210.0%
Death Rate
Active Ingredients
Semintra Telmisartan 4 Mg/Ml
Administration Routes
Oral
Species Affected
Cat 124
Most Affected Breeds
Domestic Shorthair 98
Siamese 13
Himalayan 7
Birman (Sacred Birman) 2
Cat (other) 2
Domestic Longhair 1
Bengal 1
Most Reported Reactions
Vomiting 24
Weight loss 14
Death by euthanasia 14
Decreased appetite 12
Dehydration 10
Dental disease 8
Constipation 7
Urinary tract infection 6
Lethargy (see also Central nervous system depression in 'Neurological') 6
Haematuria 6
Inappetence 5
Heart murmur 5
Outcome Breakdown
Outcome Unknown
60 (48.4%)
Recovered/Normal
27 (21.8%)
Ongoing
22 (17.7%)
Euthanized
14 (11.3%)
Died
1 (0.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.